Halcyon is designed to simplify and enhance virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and resulting outcomes. The three additional cancer centers that have now installed the treatment system include:
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
[email protected]
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
[email protected]
SOURCE Varian
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
